These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 28651173)

  • 1. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
    Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots.
    Schauer AP; Sykes C; Cottrell ML; Prince H; Kashuba ADM
    J Pharm Biomed Anal; 2018 Feb; 149():40-45. PubMed ID: 29100029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
    Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
    J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs.
    Waitt C; Olagunju A; Nakalema S; Kyohaire I; Owen A; Lamorde M; Khoo S
    J Antimicrob Chemother; 2018 Apr; 73(4):1013-1019. PubMed ID: 29309634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
    Olagunju A; Amara A; Waitt C; Else L; Penchala SD; Bolaji O; Soyinka J; Siccardi M; Back D; Owen A; Khoo S
    J Antimicrob Chemother; 2015 Oct; 70(10):2816-22. PubMed ID: 26108608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of intracellular tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots for pre-exposure prophylaxis adherence.
    Tsuchiya K; Hayashi Y; Ryu S; Tran HT; Takano M; Tanaka K; Mizushima D; Oka S; Gatanaga H; Hamada A
    J Infect Chemother; 2024 Sep; 30(9):876-880. PubMed ID: 38431219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
    Castillo-Mancilla J; Seifert S; Campbell K; Coleman S; McAllister K; Zheng JH; Gardner EM; Liu A; Glidden DV; Grant R; Hosek S; Wilson CM; Bushman LR; MaWhinney S; Anderson PL
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6692-6697. PubMed ID: 27572401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
    Delahunty T; Bushman L; Robbins B; Fletcher CV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1907-14. PubMed ID: 19493710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.
    Gandhi M; Glidden DV; Liu A; Anderson PL; Horng H; Defechereux P; Guanira JV; Grinsztejn B; Chariyalertsak S; Bekker LG; Grant RM;
    J Infect Dis; 2015 Nov; 212(9):1402-6. PubMed ID: 25895984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System.
    Ganz N; Singrasa M; Nicolas L; Gutierrez M; Dingemanse J; Döbelin W; Glinski M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():50-60. PubMed ID: 22227055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a LC-MS/MS method for the quantification of tenofovir and emtricitabine in seminal plasma.
    Illamola SM; Valade E; Hirt D; Dulioust E; Zheng Y; Wolf JP; Tréluyer JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():234-241. PubMed ID: 27571683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids.
    Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA
    J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
    Valluru RK; B PB; S KS; V PK; Kilaru NB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():117-26. PubMed ID: 23774246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
    Zheng JH; Guida LA; Rower C; Castillo-Mancilla J; Meditz A; Klein B; Kerr BJ; Langness J; Bushman L; Kiser J; Anderson PL
    J Pharm Biomed Anal; 2014 Jan; 88():144-51. PubMed ID: 24055850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.
    Olagunju A; Bolaji OO; Amara A; Waitt C; Else L; Soyinka J; Adeagbo B; Adejuyigbe E; Siccardi M; Back D; Owen A; Khoo S
    J Antimicrob Chemother; 2015 Feb; 70(2):555-61. PubMed ID: 25326089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
    Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid.
    Ocque AJ; Hagler CE; Morse GD; Letendre SL; Ma Q
    J Pharm Biomed Anal; 2018 Jul; 156():163-169. PubMed ID: 29709783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
    Oliveira RV; Henion J; Wickremsinhe ER
    Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2415-26. PubMed ID: 25303470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Patel SH; Ismaiel OA; Mylott WR; Yuan M; Hauser KF; McRae M
    Anal Chim Acta; 2019 May; 1056():79-87. PubMed ID: 30797464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
    Bushman LR; Kiser JJ; Rower JE; Klein B; Zheng JH; Ray ML; Anderson PL
    J Pharm Biomed Anal; 2011 Sep; 56(2):390-401. PubMed ID: 21715120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.